MAPT and Alzheimer disease: In the total study group significant associations between CSF levels of RTN-4 and classical AD biomarkers, such as Aβ-42/Aβ-40 ratio (p < 0.001), tau (p < 0.001), and pTau (p < 0.001) were found.